Literature DB >> 11721743

Comparison of dopamine and norepinephrine after traumatic brain injury and hypoxic-hypotensive insult.

C Ract1, B Vigué, N Bodjarian, J X Mazoit, K Samii, M Tadié.   

Abstract

After severe brain trauma, blood-brain barrier disruption and alteration of cerebral arteriolar vasoreactive properties may modify the cerebral response to catecholamines. Therefore, the goal of the present study was to compare the effects of dopamine and norepinephrine in a model of brain injury that consisted of a weight-drop model of injury complicated by a 15-min hypoxic-hypotensive insult (HH). Sprague-Dawley rats (n = 7 in each group) received, after brain injury, an infusion of either norepinephrine (TNE group) or dopamine (TDA group) in order to increase cerebral perfusion pressure (CPP) above 70 mm Hg. In addition, a control group (C group, no trauma) and a trauma group (T group, brain injury, no catecholamine infusion) were studied. Mean arterial pressure (MAP), intracranial pressure (ICP, intraparenchymal fiberoptic device), and local cerebral blood flow (LCBF, extradural laser-Doppler fiber) were measured throughout the protocol. In T group, brain injury and HH induced a decrease in CPP (by an increase of ICP and a decrease of MAP), and a decrease of LCBF. Both norepinephrine and dopamine failed to increase CPP, and ICP was significantly higher in TNE and TDA groups than in T group. Interestingly, norepinephrine was not able to alleviate the decrease in MAP. Neither norepinephrine or dopamine could induce an increase of MAP. LCBF decreased similarly in T, TNE and TDA groups. In conclusion, norepinephrine and dopamine are not able to restore values of CPP above 70 mm Hg in a model of severe brain trauma. Furthermore, their systemic vasopressor properties are altered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11721743     DOI: 10.1089/089771501317095287

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  8 in total

1.  Vasopressor use and effect on blood pressure after severe adult traumatic brain injury.

Authors:  Pimwan Sookplung; Arunotai Siriussawakul; Amin Malakouti; Deepak Sharma; Jin Wang; Michael J Souter; Randall M Chesnut; Monica S Vavilala
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 2.  Role of vasopressor administration in patients with acute neurologic injury.

Authors:  Katie M Muzevich; Stacy A Voils
Journal:  Neurocrit Care       Date:  2009-04-22       Impact factor: 3.210

Review 3.  Practical aspects of bedside cerebral hemodynamics monitoring in pediatric TBI.

Authors:  Anthony A Figaji
Journal:  Childs Nerv Syst       Date:  2010-04       Impact factor: 1.475

4.  Use and effect of vasopressors after pediatric traumatic brain injury.

Authors:  Jane L Di Gennaro; Christopher D Mack; Amin Malakouti; Jerry J Zimmerman; William Armstead; Monica S Vavilala
Journal:  Dev Neurosci       Date:  2010-12-02       Impact factor: 2.984

5.  Post-traumatic hypoxia exacerbates neuronal cell death in the hippocampus.

Authors:  Jun-feng Feng; Xueren Zhao; Gene G Gurkoff; Ken C Van; Kiarash Shahlaie; Bruce G Lyeth
Journal:  J Neurotrauma       Date:  2012-01-30       Impact factor: 5.269

6.  COMT genotype and resting brain perfusion in children.

Authors:  Moriah E Thomason; Christian E Waugh; Gary H Glover; Ian H Gotlib
Journal:  Neuroimage       Date:  2009-06-12       Impact factor: 6.556

7.  Posttraumatic brain vulnerability to hypoxia-hypotension: the importance of the delay between brain trauma and secondary insult.

Authors:  Thomas Geeraerts; Arnaud Friggeri; Jean-Xavier Mazoit; Dan Benhamou; Jacques Duranteau; Bernard Vigué
Journal:  Intensive Care Med       Date:  2007-10-16       Impact factor: 17.440

8.  The cerebrovascular response to norepinephrine: A scoping systematic review of the animal and human literature.

Authors:  Logan Froese; Joshua Dian; Alwyn Gomez; Bertram Unger; Frederick A Zeiler
Journal:  Pharmacol Res Perspect       Date:  2020-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.